An exploratory study on the effect of kynurenine metabolites on sEnd-2 endothelioma cells

Show simple item record

dc.contributor.author Nkandeu, D.S. (Danielle Sandra)
dc.contributor.author Joubert, Anna Margaretha
dc.contributor.author Serem, June Cheptoo
dc.contributor.author Bipath, Priyesh
dc.contributor.author Hlophe, Yvette Nkondo
dc.date.accessioned 2024-09-12T09:14:33Z
dc.date.available 2024-09-12T09:14:33Z
dc.date.issued 2024-06
dc.description DATA AVAILABILITY STATEMENT : The data that support the findings of this study are available from the corresponding author upon reasonable request. en_US
dc.description.abstract Cancer is the second leading cause of mortality worldwide. The development of anticancer therapy plays a crucial role in mitigating tumour progression and metastasis. Epithelioid hemangioendothelioma is a very rare cancer, however, with a high systemic involvement. Kynurenine metabolites which include l-kynurenine, 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid have been shown to inhibit T-cell proliferation resulting in a decrease in cell growth of natural killer cells and T cells. Furthermore, metabolites such as l-kynurenine have been shown to inhibit proliferation of melanoma cells in vitro. Considering these metabolite properties, the present study aimed to explore the in vitro effects of l-kynurenine, quinolinic acid and kynurenic acid on endothelioma sEnd-2 cells and on endothelial (EA. hy926 cells) (control cell line). The in vitro effect at 24, 48, and 72 h exposure to a range of 1−4 mM of the respective kynurenine metabolites on the two cell lines in terms of cell morphology, cell cycle progression and induction of apoptosis was assessed. The half inhibitory concentration (IC50), as determined using nonlinear regression, for l-kynurenine, quinolinic acid and kynurenic acid was 9.17, 15.56, and 535.40 mM, respectively. Optical transmitted light differential interference contrast and hematoxylin and eosin staining revealed cells blocked in metaphase, formation of apoptotic bodies and compromised cell density in l-kynurenine-treated cells. A statistically significant increase in the number of cells present in the sub-G1 phase was observed in l-kynurenine-treated sample. To our knowledge, this was the first in vitro study conducted to investigate the mechanism of action of kynurenine metabolites on endothelioma sEnd-2 cells. It can be concluded that l-kynurenine exerts an antiproliferative effect on the endothelioma sEnd-2 cell line by decreasing cell growth and proliferation as well as a metaphase block. These hallmarks suggest cell death via apoptosis. Further research will be conducted on l-kynurenine to assess the effect on cell adhesion in vitro and in vivo as cell-cell adhesion has been shown to increase metastasis to distant organs therefore, the inhibition of adhesion may lead to a decrease in metastasis. en_US
dc.description.department Anatomy en_US
dc.description.department Physiology en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The National Research Foundation (NRF) and the University Capacity Development Programme (UCDP). en_US
dc.description.uri https://wileyonlinelibrary.com/journal/cbf en_US
dc.identifier.citation Nkandeu, D.S., Joubert, A.M., Serem, J.C., Bipath, P. & Hlophe, Y.N. An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells. Cell Biochemistry and Function 2024; 42: e4065. doi: 10.1002/cbf.4065 en_US
dc.identifier.issn 0263-6484 (print)
dc.identifier.issn 1099-0844 (online)
dc.identifier.other 10.1002/cbf.4065
dc.identifier.uri http://hdl.handle.net/2263/98150
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.rights © 2024 The Author(s). Cell Biochemistry and Function published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License. en_US
dc.subject Apoptosis en_US
dc.subject Endothelioma en_US
dc.subject Kynurenic acid en_US
dc.subject l-kynurenine en_US
dc.subject Quinolinic acid en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title An exploratory study on the effect of kynurenine metabolites on sEnd-2 endothelioma cells en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record